Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin

Clinical trial NCT05069688 · RECRUITING

Trial details

NCT number: NCT05069688
Sponsor: Brigham and Women's Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pediatric HIV Infection Tuberculosis Infection

Start date: 2023-07-07
Primary completion: 2026-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.